Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
Open accessThe DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Abstract
Background Genexol-PM is a novel Cremophor EL (CrEL)-free polymeric micelle formulation of paclitaxel (Taxol). This multicenter phase II study was designed to evaluate the efficacy and safety of the combination of Genexol-PM and cisplatin for the treatment of advanced non-small-cell lung cancer (NSCLC).Patients and methods Patients with advanced NSCLC received Genexol-PM 230 mg/m(2) and cisplatin 60 mg/m(2) on day 1 of a 3-week cycle as first-line therapy. Intrapatient dose escalation of Genexol-PM to 300 mg/m(2) was carried out from the second cycle if the prespecified toxic effects were not observed after the first cycle.Results Sixty-nine patients were enrolled in this study. Overall response rate was 37.7%. The median time to progression was 5.8 months and the median survival period was 21.7 months. The major non-hematologic toxic effects included grade 3 peripheral sensory neuropathy (13.0%) and grade 3/4 arthralgia (7.3%). Four patients (5.8%) experienced grade 3/4 hypersensitivity reactions. The major hematological toxic effects were grade 3/4 neutropenia (29.0% and 17.4%, respectively).Conclusion Genexol-PM plus cisplatin combination chemotherapy showed significant antitumor activity. The use of CrEL-free, polymeric micelle formulation of paclitaxel allowed administration of higher doses of paclitaxel compared with the CrEL-based formulation without significant increased toxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although Genexol® PM has shown some hypersensitivity reaction in the clinic, probably due to the PEG, this is not nearly as much of a concern as for Taxol® which contains Cremophor EL [301].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [301]
In the citing paper
“The overall response rate was 37.7% and the median survival period was 21.7 months, which indicated significant improvements compared to previous clinical trials conducted with Taxol® 175–200 mg/m2 and cisplatin 75–80 mg/m2 [301].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [301]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Self-citationIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Self-citation
Cited by
Items 201–300 of 391
Shea, J., Nam, K.-H., Rapoport, N. Y., & Scaife, C. L. (2011) · HPB · doi:10.1111/j.1477-2574.2010.00249.x · Cited by 23
Platinum in Biomedical Applications
Sinitsyna, O. V., Paralikar, P., Pandit, R., & Rai, M. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-74814-6_7 · Cited by 22
Zhang, Y., Huang, Y., Zhao, W., Lu, J., Zhang, P., Zhang, X., Li, J., Gao, X., Venkataramanan, R., & Li, S. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9651-2 · Cited by 22
Li, F., Zhang, H., He, M., Liao, J., Chen, N., Li, Y., Zhou, S. Y., Palmisano, M., Yu, A., Pai, M. P., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00527 · Cited by 22
Development of bioactive materials for glioblastoma therapy
Yang, J., Li, Y., Zhang, T., & Zhang, X. (2016) · Bioactive Materials · doi:10.1016/j.bioactmat.2016.03.003 · Cited by 21
Maikawa, C. L., Sevit, A. M., Lin, B., Wallstrom, R. J., Mann, J. L., Yu, A. C., Waymouth, R. M., & Appel, E. A. (2019) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.29393 · Cited by 21
Liu, X., Sun, J., Chen, X., Wang, S., Scott, H., Zhang, X., & Zhang, Q. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01471.x · Cited by 21
Martins, C., & Sarmento, B. F. C. C. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1893 · Cited by 20
Verma, R., Rao, L., Nagpal, D., Yadav, M., Kumar, V., Kumar, V., Kumar, H., Parashar, J., Bansal, N., Kumar, M., et al. (2023) · Recent Patents on Nanotechnology · doi:10.2174/1872210517666230613154847 · Cited by 20
Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy
Shin, D. H., & Kwon, G. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.006 · Cited by 20
Wang, X., Meng, N., Wang, S., Lu, L., Wang, H., Zhan, C., Burgess, D. J., & Lu, W. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00394 · Cited by 20
Fernández, Y., Movellan, J., Foradada, L., Giménez, V., García‐Aranda, N., Mancilla, S., Armiñán, A., Borgos, S. E., Hyldbakk, A., Bogdanska, A., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101544 · Cited by 20
EFFECTS OF POLYMERIC NANOPARTICLE SURFACE PROPERTIES ON INTERACTION WITH BRAIN TUMOR ENVIRONMENT
Mattix, B., Moore, T. L., Uvarov, O., Pollard, S., O’Donnell, L. A., PARK, K., Horne, D., Dhulekar, J., Reese, L. M., Nguyen, D. T., et al. (2013) · Nano LIFE · doi:10.1142/s1793984413430034 · Cited by 20
Self-citationNatural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy
Liao, W., Li, Y., Wang, J., Zhao, M., Chen, N., Zheng, Q., Wan, L., Mou, Y., Tang, J., & Wang, Z. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s380697 · Cited by 19
Protein-based nanocarriers for paclitaxel (PTX) delivery in cancer treatment: A review
Abbaspour, S., Mohamadzadeh, M., & Shojaosadati, S. A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143068 · Cited by 19
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review
Gholami, L., Ivari, J. R., Nasab, N. K., Oskuee, R. K., Sathyapalan, T., & Sahebkar, A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210810160901 · Cited by 20
Seshadri, D. R., & Ramamurthi, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00759 · Cited by 19
Gordon, M. R., Zhuang, J., Ventura, J., Li, L., Raghupathi, K., & Thayumanavan, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01011 · Cited by 18
Ouahab, A., Shao, C., Shen, Y., & Tu, J. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.788017 · Cited by 18
Polymeric capsules and micelles as promising carriers of anticancer drugs
Kubiak, T. (2022) · Polymers in Medicine · doi:10.17219/pim/145513 · Cited by 17
Nanoparticles as drug carriers
Patravale, V. B., Dandekar, P. P., & Jain, R. D. (2012) · Elsevier eBooks · doi:10.1533/9781908818195.29 · Cited by 17
Polymeric Nanoparticle-Based Drug/Gene Delivery for Lung Cancer
Ray, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815720-6.00004-6 · Cited by 17
Elsayed, N. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124819 · Cited by 16
Gut microbiome-specific nanoparticle-based therapeutics for liver diseases
Khurana, A., & Hartmann, P. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i27.109105 · Cited by 16
Digesu, C. S., Hofferberth, S. C., Grinstaff, M. W., & Colson, Y. L. (2016) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2015.12.009 · Cited by 16
Patil, S. M., Tandon, R., & Tandon, N. (2022) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2022-0010 · Cited by 15
Wang, F., Huang, X., Cao, J., Cao, J., Li, K., Li, K., Lu, M., & Huang, X. (2024) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-024-01058-y · Cited by 15
Austria, E. S., Jr., & Akhavan, B. (2025) · Nanoscale · doi:10.1039/d5nr00436e · Cited by 14
Ren, Y., Zhan, C., Gao, J., Zhang, M., Wei, X., Man, Y. M., Liu, Z., & Lu, W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00944 · Cited by 14
Mittal, A., & Chitkara, D. (2016) · Therapeutic Delivery · doi:10.4155/tde.15.90 · Cited by 14
The progress and perspective of nanomedicine in modulating the tumor immune microenvironment
Lin, N., Tan, K., Wei, Y., Xie, S., Liu, J., & Ma, X. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.002 · Cited by 13
Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment
Isaic, A., Davidescu, L., Motofelea, A. C., Ciocârlie, T., Motofelea, N., Costăchescu, D., Marc, M. S., Suppini, N., Şovrea, A. S., Coșeriu, R. L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011235 · Cited by 13
Nayak, R., Meerovich, I. G., & Dash, A. K. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1367-2 · Cited by 13
Nanoparticle-based macromolecule drug delivery to lungs
Kumar, N., Gautam, V., Kumar, V., & Maurya, P. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820658-4.00011-x · Cited by 13
Balaure, P. C., & Grumezescu, A. M. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140304103437 · Cited by 13
Nanoformulations in the treatment of lung cancer: current status and clinical potential
Younis, M. A., Alsogaihi, M. A., Abdellatif, A. A. H., & Saleem, I. Y. (2024) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2024.2437562 · Cited by 12
Translational Nano-medicine Lab to Clinic
Khan, M. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817830-0.00008-4 · Cited by 12
A Review-Emerging Use of Nano-Based Carriers in Diagnosis and Treatment of Cancer-Novel Approaches
Khan, Y., Saroj, B. K., Roy, M., & Aziz, I. (2015) · Asian Journal of Pharmacy and Technology · doi:10.5958/2231-5713.2015.00008.2 · Cited by 12
Cytoplasm-Responsive Delivery Systems for siRNA Using Cell-Penetrating Peptide Nanomicelles
Okada, H., Ogawa, T., Tanaka, K., Kanazawa, T., & Takashima, Y. (2014) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(14)50001-9 · Cited by 12
Reinvention of chemotherapy: drug conjugates and nanoparticles
Nguyen‐Ngoc, T., & Raymond, É. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000183 · Cited by 12
Asakura, T., Yokoyama, M., SHIRAISHI, K., Aoki, K., & Ohkawa, K. (2018) · Anticancer Research · doi:10.21873/anticanres.12353 · Cited by 12
van Gaal, E. V. B., & Crommelin, D. J. A. (2015) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-16241-6_2 · Cited by 12
Drug delivery applications of injectable biomaterials
Overstreet, D. J., von Recum, H. A., & Vernon, B. L. (2011) · Elsevier eBooks · doi:10.1533/9780857091376.2.95 · Cited by 12
Zhou, S. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12089 · Cited by 12
Advances in Polymer Micelles for Cancer Therapy: From Conventional to Smart Delivery Systems
Bryaskova, R. G., Staykov, K., & Ganchev, D. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020177 · Cited by 11
Lipid Spheres as Attractive Nanoscale Drug Delivery Platforms for Cancer Therapy
Uckun, F. M. (2011) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000128 · Cited by 11
The Emerging Role of Ultrasonic Nanotechnology for Diagnosing and Treatment of Diseases
Liu, X., & Ge, W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.814986 · Cited by 11
Recent Updates on Polymeric Micelles: A Review
Pawar, A., Kamdi, V., Alaspure, A., & Gangane, P. S. (2022) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2022.v73i01.010 · Cited by 12
Enhanced Vascular Permeability in Solid Tumors: A Promise for Anticancer Nanomedicine
Taurin, S., & Greish, K. F. (2013) · Cancer metastasis · doi:10.1007/978-94-007-6028-8_4 · Cited by 11
Carboxylesterase-Triggered Hydrolysis of Nanoparticle PEGylating Agents
Howard, M. D., Lü, X., Rinehart, J. J., Jay, M., & Dziubla, T. D. (2012) · Langmuir · doi:10.1021/la302144r · Cited by 11
Nanomaterial-assisted pancreatic cancer theranostics
Liu, Y., Xu, H., Bai, S., Chen, T., Ma, X., Lin, J., Sun, L., Gao, C., Wu, A., & Li, Q. (2025) · Regenerative Biomaterials · doi:10.1093/rb/rbaf054 · Cited by 10
Tang, Y., Lu, S., Liang, W., He, Y., Hao, J., Xu, W., Sun, Y., & Zhan, C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114465 · Cited by 10
Chen, X., Yang, X., Chen, X., Cheng, Y., & Li, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126031 · Cited by 9
The Sojourn of Polymeric Micelles for Effective Brain Drug Delivery System
Kaur, P., Rajput, A., Singh, D., Singh, G., Mehra, A., Kaur, S., Bedi, N., & Arora, S. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230413082352 · Cited by 9
Theranostic Polymeric Nanoparticles for Cancer
Fernandes, D. A. (2023) · BioNanoScience · doi:10.1007/s12668-023-01151-9 · Cited by 9
Self-assembled lipid-based nanoparticles for chemotherapy against breast cancer
Liu, S. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1482637 · Cited by 9
Micellar-Based Nanoparticles for Cancer Therapy and Bioimaging
Andrade, F., Almeida, A., Rafael, D. F. D. S., Schwartz, S., & Sarmento, B. F. C. C. (2018) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-319-89878-0_6 · Cited by 9
Major Nano-based Products: Nanomedicine, Nanosensors, and Nanodiagnostics
Khan, F. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-4802-4_11 · Cited by 9
Md, S., Alhakamy, N. A., Karim, S., Gabr, G. A., Iqubal, M. K., & Murshid, S. S. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122120 · Cited by 9
Hafezi, M., & Sharif, F. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.09.005 · Cited by 9
Preparation and Optimization of PEG-PLGA Loaded with Vincristine Sulfate and its In vitro Release
Wen, J., Tingting, G., & Hong-Yuan, Z. (2011) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000088 · Cited by 9
Application of biomaterials for glioblastoma treatment: Promises, advances, and challenges
Abdul‐Al, M., Saeinasab, M., Zare, A., Barati, M., Shakeri, S., Keykhosravi, E., Momeni‐Moghaddam, M., Najafzadeh, M., Keshel, S. H., Farzi, G., et al. (2022) · Materials Today Communications · doi:10.1016/j.mtcomm.2022.104562 · Cited by 8
Nano-based drug delivery system
Eskiler, G. G., Dıkmen, G., & Genc, L. (2015) · IAPC Publishing eBooks · doi:10.5599/obp.8.3 · Cited by 8
Targeted polymeric micellar systems for respiratory diseases
Virmani, R., & Pathak, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820658-4.00020-0 · Cited by 9
Lv, F., Cao, J., Zhang, J., Qian, J., Peng, W. J., Sun, S., Li, W., Zhang, W., Guo, W., & Li, J. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2452-6 · Cited by 8
Potential of nanoparticles as drug delivery system for cancer treatment
Pelissari, F. M., Neri-Numa, I. A., Molina, G., Ferreira, D., & Pastore, G. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813741-3.00019-4 · Cited by 9
Polymeric Micelles in Management of Lung Cancer
Bahman, F., Elkaissi, S., Greish, K. F., & Taurin, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815720-6.00008-3 · Cited by 8
Expanding the nanotherapeutic toolbox for non-small-cell lung cancer
Jee, J., & Li, B. T. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.010 · Cited by 8
Tumor evolution-targeted nanomedicineEVT
Zhang, L., Yang, J., Tang, D., Zhang, H., Ding, J., & Xiao, H. (2022) · Scientia Sinica Chimica · doi:10.1360/ssc-2022-0158 · Cited by 7
Effects of block copolymer micelles on the pharmacokinetics of encapsulated drugs
Binkhathlan, Z., & Lavasanifar, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816200-2.00017-7 · Cited by 7
Characterization of drug-loaded nanoparticles
Kalashnikova, I. V., Albekairi, N. A., Al-Enazy, S., & Rytting, E. (2015) · IAPC Publishing eBooks · doi:10.5599/obp.8.4 · Cited by 7
Core-Shell Nanoparticles for Pulmonary Drug Delivery
Ratnaparkhi, M. P., Salvankar, S. S., Tekade, A. R., & Kulkarni, G. M. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385277725231120043600 · Cited by 6
Ravikumar, L., & Velmurugan, R. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i3.49358 · Cited by 7
Nevala, W. K., Geng, L., Xie, H., Stueven, N. A., & Markovic, S. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073295 · Cited by 8
Nanoformulations: Reforming treatment for non-small cell lung cancer metastasis
Jha, S., Hegde, M., Banerjee, R., Alqahtani, M. S., Abbas, M., Fardoun, H. M., Unnikrishnan, J., Sethi, G., & Kunnumakkara, A. B. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116928 · Cited by 6
Nanocarrier-based insulin delivery: A leap towards a needle-free future
Balasubramaniyam, S., Rathinam, T., Srinivasan, M., & Jayarani, S. (2025) · Nano TransMed · doi:10.1016/j.ntm.2025.100093 · Cited by 6
Synthesis and Evaluation of a Paclitaxel-Binding Tripeptide Micelle for Lung Cancer Therapy
Gao, J., Jia, Y., Taledaohan, A., Tuohan, M., Hu, X., Li, L., Li, Y., & Wang, Y. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00178 · Cited by 6
Caruso, G., Merlo, L., & Caffo, M. (2014) · Elsevier eBooks · doi:10.1533/9781908818744.53 · Cited by 6
Nanomaterials for Management of Lung Disorders and Drug Delivery
Menon, J. U., Wadajkar, A. S., Xie, Z., & Nguyen, K. T. (2013) · Wiley eBooks · doi:10.1002/9781118644591.ch5 · Cited by 6
Advances in carrier-free nanodrug delivery systems
Liu, J.-Y., Zheng, Y.-Y., Wang, S.-Y., Bi, Y., Sun, M., Hao, J.-F., & He, Y.-J. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02118-5 · Cited by 5
Implementation of Nanoparticles in Cancer Therapy
Bayır, E., Bilgi, E., & Şendemir, A. (2014) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-4666-5824-0.ch018 · Cited by 5
Amphiphilic Block Copolymer Based Nanocarriers for Drug and Gene Delivery
Xiong, X.-B., & Lavasanifar, A. (2011) · Fundamental biomedical technologies · doi:10.1007/978-94-007-1248-5_10 · Cited by 5
Self-assembling biomaterials for theranostic applications
Bhuiyan, Z. H., Anderson, C. F., & Cui, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-102015-9.00025-3 · Cited by 5
Tumor‐Targeted Nanoparticles: State‐of‐the‐Art and Remaining Challenges
Bajaj, G., & Yeo, Y. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse488 · Cited by 5
Nanoparticle-Based Cancer Treatment: Limitations, Challenges, and Future Applications
Bellah, S. F., Shadin, A. O., & Durojaye, O. A. (2024) · Pharmacy and Drug Development · doi:10.58489/2836-2322/036 · Cited by 4
Sohail, M., Chen, W., Younas, A., Iqbal, S., Yang, B., Qiu, F., Shu, G., Chen, M., Tu, J., Yuan, H., et al. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214987 · Cited by 5
Polymeric Micelles for Cancer‐Targeted Drug Delivery
Chen, H., Ge, Z., & Kataoka, K. (2014) · Wiley eBooks · doi:10.1002/9783527672752.ch4 · Cited by 4
What Is the Role of Novel Taxanes in Non–Small-Cell Lung Cancer?
Spigel, D. R., & Greco, F. (2008) · Clinical Lung Cancer · doi:10.3816/clc.2008.s.017 · Cited by 4
Taxane Formulations: From Plant to Clinic
Elhissi, A. M. A., Mahmood, R., Parveen, I., Vali, A. M., Ahmed, W., & Jackson, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-67132-1_2 · Cited by 4
Drug Carrier-Oriented Polygeline for Preparing Novel Polygeline-Bound Paclitaxel Nanoparticles
Xiong, K., Wu, J., Liu, Y., Wu, N., & Ruan, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.01.005 · Cited by 4
Taxane anticancer formulations: challenges and achievements
Elhissi, A. M. A., Mahmood, R., Parveen, I., Vali, A., Najlah, M., Phoenix, D. A., & Ahmed, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819712-7.00018-8 · Cited by 4
Nanomedicine Magic Bullet for Human Cancer
Patnaik, S. (2016) · IGI Global eBooks · doi:10.4018/978-1-5225-0549-5.ch014 · Cited by 4
Emerging Trends in Nanotechnology for Diagnosis and Therapy of Lung Cancer
Rohra, N., Gore, M., Dyawanapelly, S., Tambe, M., Gautam, A., Suvarna, M., Jain, R. D., & Dandekar, P. P. (2018) · CRC Press eBooks · doi:10.1201/9781351031585-4 · Cited by 4
Nano-pharmacokinetics: biodistribution and toxicology
Vibhavari, R. J. A., Kumar, G., Rao, V., Cheruku, S. P., & Kumar, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85050-6.00013-x · Cited by 4
Nanomedicine and Brain Tumors Treatment
Caruso, G., Caffo, M., Raudino, G., Tomasello, C., Alafaci, C., & Tomasello, F. F. (2012) · Springer eBooks · doi:10.1007/978-3-642-29265-1_6 · Cited by 4
Recent Advances in Nanocarrier-Based Drug Delivery Systems for Lung Cancer
Li, Z., Liu, C., Di, Z., Zhang, G., You, S., Chao, S., & Ren, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s577151 · Cited by 3
Advancing Small-Molecule Immunotherapy Through Polymeric Micelle Delivery
Suwal, K., Lee, H., Bashyal, S., Kim, D., Cho, H. J., & Hwang, D. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18040418 · Cited by 3
Self-citationNanoparticles as Targeted Drug Delivery Agents: Synthesis, Mechanism and Applications
Rahisuddin, R., Nayab, P. S., Akrema, A., Arif, R., & Abid, M. (2017) · Advanced structured materials · doi:10.1007/978-981-10-3842-6_3 · Cited by 3
Regulatory Considerations for Cancer Drug Products Containing Nanomaterials
Kapoor, M., Hughes, K., & Tyner, K. M. (2018) · Bioanalysis · doi:10.1007/978-3-030-01775-0_12 · Cited by 3
Polymeric micelles in dermal and transdermal drug delivery
Ali, M. A., & Gould, M. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00009-4 · Cited by 3
Metadata
- Authors
- Kim, D.-W., Kim, S.-Y., Kim, H.-K., Kim, S.-W., Shin, S. W., Kim, J. S., Park, K., Lee, M. Y., & Heo, D. S.
- Affiliations
- Seoul National University (KR)
- Asan Medical Center (KR)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- Korea University Anam Hospital (KR)
- Samsung Medical Center (KR)
- Samyang Holdings (South Korea) (KR)
- Corresponding author
- Heo, D.S.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 18
- Issue
- 12
- Pages
- 2009-2014
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2155680971
- Cited by
- 356
- References
- 27
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 19 · 2023: 13 · 2022: 24 · 2021: 12 · 2020: 22 · 2019: 15 · 2018: 19 · 2017: 18 · 2016: 30 · 2015: 24 · 2014: 31 · 2013: 28 · 2012: 17
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4385 d)
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- paclitaxel, polymeric micelles, cisplatin, non-small cell lung cancer, combination chemotherapy, first-line therapy, dose escalation, peripheral sensory neuropathy, neutropenia, hypersensitivity, anticancer activity
- MeSH terms
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Cisplatin, Female, Humans, Lung Neoplasms, Male, Micelles, Middle Aged, Polymers, Treatment Outcome, Paclitaxel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.